デフォルト表紙
市場調査レポート
商品コード
1171971

世界の非侵襲的な非経口的スクリーニング機器市場:産業調査報告書、成長動向と競合分析 (2022年~2028年)

Global Non-invasive Parenteral Screening Instruments Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

出版日: | 発行: QYResearch | ページ情報: 英文 119 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
世界の非侵襲的な非経口的スクリーニング機器市場:産業調査報告書、成長動向と競合分析 (2022年~2028年)
出版日: 2022年12月14日
発行: QYResearch
ページ情報: 英文 119 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、非侵襲的な非経口的スクリーニング機器 (Non-invasive Parenteral Screening Instruments) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査対象範囲
  • 市場 セグメントタイプ別
    • 世界の非侵襲的な非経口的スクリーニング機器の市場規模成長率:タイプ別 (2017 VS 2021 VS 2028)
    • Ultrasound Devices
    • Next-Generation Sequencing Systems
    • Polymerase Chain Reaction Instruments
    • Microarrays
    • Others
  • 市場セグメント:用途別
    • 世界の非侵襲的な非経口的スクリーニング機器の市場シェア:用途別 (2017 VS 2021 VS 2028)
    • Diagnostic Laboratories
    • Hospitals
  • 調査目的
  • 対象期間

第2章 市場展望

  • 世界の非侵襲的な非経口的スクリーニング機器 市場規模 (2017-2028)
    • 世界の非侵襲的な非経口的スクリーニング機器の収益 (2017-2028)
    • 世界の非侵襲的な非経口的スクリーニング機器 売上 (2017-2028)
  • 世界の非侵襲的な非経口的スクリーニング機器 世界の主要地域における市場規模: 2017 VS 2021 VS 2028
    • 世界の非侵襲的な非経口的スクリーニング機器 販売:地域別 (2017-2022)
    • 世界の非侵襲的な非経口的スクリーニング機器 収益:地域別 (2017-2022)
  • 世界の非侵襲的な非経口的スクリーニング機器 市場規模予測:地域別
    • 世界の非侵襲的な非経口的スクリーニング機器の販売予測:地域別 (2023-2028)
    • 世界の非侵襲的な非経口的スクリーニング機器の収益予測:地域別 (2023-2028)
  • 世界のトップ 非侵襲的な非経口的スクリーニング機器 地域(国) ランキング別 市場規模
  • 非侵襲的な非経口的スクリーニング機器 市場動向
    • 非侵襲的な非経口的スクリーニング機器 市場トレンド
    • 非侵襲的な非経口的スクリーニング機器 市場の促進要因
    • 非侵襲的な非経口的スクリーニング機器 市場の課題
    • 非侵襲的な非経口的スクリーニング機器 市場の抑制要因

第3章 競争状況:企業別

  • 世界のトップ 非侵襲的な非経口的スクリーニング機器の上位企業:販売別 (2017-2022)
    • 世界の非侵襲的な非経口的スクリーニング機器の販売:企業別 (2017-2022)
    • 世界の非侵襲的な非経口的スクリーニング機器の販売市場シェア:企業別 (2017-2022)
    • 世界の5大・10大企業 非侵襲的な非経口的スクリーニング機器 売上2021
  • 世界のトップ 企業 非侵襲的な非経口的スクリーニング機器 収益別
    • 世界の非侵襲的な非経口的スクリーニング機器の収益:企業別 (2017-2022)
    • トップ 非侵襲的な非経口的スクリーニング機器 企業:収益別ランキング
    • 世界の非侵襲的な非経口的スクリーニング機器の収益シェア:企業別 (2017-2022)
    • 世界の非侵襲的な非経口的スクリーニング機器 市場集中度 (CR5 ・ HHI)
  • 世界のトップ 企業 企業タイプ別 (Tier 1, Tier 2 ・ Tier 3) & (売上高に基づいた非侵襲的な非経口的スクリーニング機器 (2021年時点))
  • 世界の非侵襲的な非経口的スクリーニング機器 企業別平均販売価格(ASP)
  • 主要企業 非侵襲的な非経口的スクリーニング機器 工場・事業所分布と供給地域
  • 主要企業の参入時期 非侵襲的な非経口的スクリーニング機器 市場
  • 主要企業 非侵襲的な非経口的スクリーニング機器 取扱商品
  • M&A, 拡張計画

第4章 世界の非侵襲的な非経口的スクリーニング機器 市場規模:タイプ別

  • 世界の非侵襲的な非経口的スクリーニング機器の過去の市場概要:タイプ別 (2017-2022)
    • 世界の非侵襲的な非経口的スクリーニング機器の販売市場シェア:タイプ別 (2017-2022)
    • 世界の非侵襲的な非経口的スクリーニング機器の収益市場シェア:タイプ別 (2017-2022)
    • 非侵襲的な非経口的スクリーニング機器の価格:タイプ別 (2017-2022)
  • 世界の非侵襲的な非経口的スクリーニング機器の市場 推定および予測:タイプ別 (2023-2028)
    • 世界の非侵襲的な非経口的スクリーニング機器の販売予測:タイプ別 (2023-2028)
    • 世界の非侵襲的な非経口的スクリーニング機器の収益予測:タイプ別 (2023-2028)
    • 非侵襲的な非経口的スクリーニング機器の価格予測:タイプ別 (2023-2028)

第5章 世界の非侵襲的な非経口的スクリーニング機器 市場規模:用途別

  • 世界の非侵襲的な非経口的スクリーニング機器の過去の市場概要:用途別 (2017-2022)
    • 世界の非侵襲的な非経口的スクリーニング機器の販売市場シェア:用途別 (2017-2022)
    • 世界の非侵襲的な非経口的スクリーニング機器の収益市場シェア:用途別 (2017-2022)
    • 非侵襲的な非経口的スクリーニング機器の価格:用途別 (2017-2022)
  • 世界の非侵襲的な非経口的スクリーニング機器の市場 推定および予測:用途別 (2023-2028)
    • 世界の非侵襲的な非経口的スクリーニング機器の販売予測:用途別 (2023-2028)
    • 世界の非侵襲的な非経口的スクリーニング機器の収益予測:用途別 (2023-2028)
    • 非侵襲的な非経口的スクリーニング機器の価格予測:用途別 (2023-2028)

第6章 北米

  • 北米の非侵襲的な非経口的スクリーニング機器 売上内訳:企業別
    • 北米の非侵襲的な非経口的スクリーニング機器 売上:企業別 (2017-2022)
    • 北米の非侵襲的な非経口的スクリーニング機器 収益:企業別 (2017-2022)
  • 北米の非侵襲的な非経口的スクリーニング機器 市場規模:タイプ別
    • 北米の非侵襲的な非経口的スクリーニング機器の販売:タイプ別 (2017-2028)
    • 北米の非侵襲的な非経口的スクリーニング機器の収益:タイプ別 (2017-2028)
  • 北米の非侵襲的な非経口的スクリーニング機器 市場規模:用途別
    • 北米の非侵襲的な非経口的スクリーニング機器の販売:用途別 (2017-2028)
    • 北米の非侵襲的な非経口的スクリーニング機器の収益:用途別 (2017-2028)
  • 北米の非侵襲的な非経口的スクリーニング機器 市場規模:国別
    • 北米の非侵襲的な非経口的スクリーニング機器の販売:国別 (2017-2028)
    • 北米の非侵襲的な非経口的スクリーニング機器の収益:国別 (2017-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の非侵襲的な非経口的スクリーニング機器 売上内訳:企業別
    • 欧州の非侵襲的な非経口的スクリーニング機器 売上:企業別 (2017-2022)
    • 欧州の非侵襲的な非経口的スクリーニング機器 収益:企業別 (2017-2022)
  • 欧州の非侵襲的な非経口的スクリーニング機器 市場規模:タイプ別
    • 欧州の非侵襲的な非経口的スクリーニング機器の販売:タイプ別 (2017-2028)
    • 欧州の非侵襲的な非経口的スクリーニング機器の収益:タイプ別 (2017-2028)
  • 欧州の非侵襲的な非経口的スクリーニング機器 市場規模:用途別
    • 欧州の非侵襲的な非経口的スクリーニング機器の販売:用途別 (2017-2028)
    • 欧州の非侵襲的な非経口的スクリーニング機器の収益:用途別 (2017-2028)
  • 欧州の非侵襲的な非経口的スクリーニング機器 市場規模:国別
    • 欧州の非侵襲的な非経口的スクリーニング機器の販売:国別 (2017-2028)
    • 欧州の非侵襲的な非経口的スクリーニング機器の収益:国別 (2017-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋

  • アジア太平洋の非侵襲的な非経口的スクリーニング機器 売上内訳:企業別
    • アジア太平洋の非侵襲的な非経口的スクリーニング機器 売上:企業別 (2017-2022)
    • アジア太平洋の非侵襲的な非経口的スクリーニング機器 収益:企業別 (2017-2022)
  • アジア太平洋の非侵襲的な非経口的スクリーニング機器 市場規模:タイプ別
    • アジア太平洋の非侵襲的な非経口的スクリーニング機器の販売:タイプ別 (2017-2028)
    • アジア太平洋の非侵襲的な非経口的スクリーニング機器の収益:タイプ別 (2017-2028)
  • アジア太平洋の非侵襲的な非経口的スクリーニング機器 市場規模:用途別
    • アジア太平洋の非侵襲的な非経口的スクリーニング機器の販売:用途別 (2017-2028)
    • アジア太平洋の非侵襲的な非経口的スクリーニング機器の収益:用途別 (2017-2028)
  • アジア太平洋の非侵襲的な非経口的スクリーニング機器 市場規模:地域別
    • アジア太平洋の非侵襲的な非経口的スクリーニング機器の販売:地域別
    • アジア太平洋の非侵襲的な非経口的スクリーニング機器の収益:地域別
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • 台湾
    • インドネシア
    • タイ
    • マレーシア
    • フィリピン
    • ベトナム

第9章 ラテンアメリカ

  • ラテンアメリカの非侵襲的な非経口的スクリーニング機器 売上内訳:企業別
    • ラテンアメリカの非侵襲的な非経口的スクリーニング機器 売上:企業別 (2017-2022)
    • ラテンアメリカの非侵襲的な非経口的スクリーニング機器 収益:企業別 (2017-2022)
  • ラテンアメリカの非侵襲的な非経口的スクリーニング機器 市場規模:タイプ別
    • ラテンアメリカの非侵襲的な非経口的スクリーニング機器の販売:タイプ別 (2017-2028)
    • ラテンアメリカの非侵襲的な非経口的スクリーニング機器の収益:タイプ別 (2017-2028)
  • ラテンアメリカの非侵襲的な非経口的スクリーニング機器 市場規模:用途別
    • ラテンアメリカの非侵襲的な非経口的スクリーニング機器の販売:用途別 (2017-2028)
    • ラテンアメリカの非侵襲的な非経口的スクリーニング機器の収益:用途別 (2017-2028)
  • ラテンアメリカの非侵襲的な非経口的スクリーニング機器 市場規模:国別
    • ラテンアメリカの非侵襲的な非経口的スクリーニング機器の販売:国別 (2017-2028)
    • ラテンアメリカの非侵襲的な非経口的スクリーニング機器の収益:国別 (2017-2028)
    • メキシコ
    • ブラジル
    • アルゼンチン

第10章 中東・アフリカ

  • 中東・アフリカの非侵襲的な非経口的スクリーニング機器 売上内訳:企業別
    • 中東・アフリカの非侵襲的な非経口的スクリーニング機器 売上:企業別 (2017-2022)
    • 中東・アフリカの非侵襲的な非経口的スクリーニング機器 収益:企業別 (2017-2022)
  • 中東・アフリカの非侵襲的な非経口的スクリーニング機器 市場規模:タイプ別
    • 中東・アフリカの非侵襲的な非経口的スクリーニング機器の販売:タイプ別 (2017-2028)
    • 中東・アフリカの非侵襲的な非経口的スクリーニング機器の収益:タイプ別 (2017-2028)
  • 中東・アフリカの非侵襲的な非経口的スクリーニング機器 市場規模:用途別
    • 中東・アフリカの非侵襲的な非経口的スクリーニング機器の販売:用途別 (2017-2028)
    • 中東・アフリカの非侵襲的な非経口的スクリーニング機器の収益:用途別 (2017-2028)
  • 中東・アフリカの非侵襲的な非経口的スクリーニング機器 市場規模:国別
    • 中東・アフリカの非侵襲的な非経口的スクリーニング機器の販売:国別 (2017-2028)
    • 中東・アフリカの非侵襲的な非経口的スクリーニング機器の収益:国別 (2017-2028)
    • トルコ
    • サウジアラビア
    • U.A.E

第11章 企業プロファイル

  • GE Healthcare
  • Philips
  • Illumina
  • Thermo Fisher Scientific
  • Roche
  • PacBio
  • Perkinelmer
  • Qiagen
  • Agilent Technologies
  • BGI Group

第12章 バリューチェーンと販売チャネルの分析

  • 非侵襲的な非経口的スクリーニング機器 バリューチェーンの分析
  • 非侵襲的な非経口的スクリーニング機器 主要原材料分析
    • 主要原材料分析
    • 原材料の主要サプライヤー
  • 非侵襲的な非経口的スクリーニング機器 生産形態とプロセス
  • 非侵襲的な非経口的スクリーニング機器 販売およびマーケティング
    • 非侵襲的な非経口的スクリーニング機器 販売チャネル
    • 非侵襲的な非経口的スクリーニング機器 卸業者
  • 非侵襲的な非経口的スクリーニング機器 顧客

第13章 市場調査結果と結論

第14章 付録

図表

List of Tables

  • Table 1. Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of Ultrasound Devices
  • Table 3. Major Manufacturers of Next-Generation Sequencing Systems
  • Table 4. Major Manufacturers of Polymerase Chain Reaction Instruments
  • Table 5. Major Manufacturers of Microarrays
  • Table 6. Major Manufacturers of Others
  • Table 7. Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 8. Global Non-invasive Parenteral Screening Instruments Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
  • Table 9. Global Non-invasive Parenteral Screening Instruments Sales by Region (2017-2022) & (Units)
  • Table 10. Global Non-invasive Parenteral Screening Instruments Sales Market Share by Region (2017-2022)
  • Table 11. Global Non-invasive Parenteral Screening Instruments Revenue by Region (2017-2022) & (US$ Million)
  • Table 12. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Region (2017-2022)
  • Table 13. Global Non-invasive Parenteral Screening Instruments Sales Forecast by Region (2023-2028) & (Units)
  • Table 14. Global Non-invasive Parenteral Screening Instruments Sales Market Share Forecast by Region (2023-2028)
  • Table 15. Global Non-invasive Parenteral Screening Instruments Revenue Forecast by Region (2023-2028) & (US$ Million)
  • Table 16. Global Non-invasive Parenteral Screening Instruments Revenue Market Share Forecast by Region (2023-2028)
  • Table 17. Top Non-invasive Parenteral Screening Instruments Regions (Countries) Ranking by Market Size (US$ Million) in 2021
  • Table 18. Non-invasive Parenteral Screening Instruments Market Trends
  • Table 19. Non-invasive Parenteral Screening Instruments Market Drivers
  • Table 20. Non-invasive Parenteral Screening Instruments Market Challenges
  • Table 21. Non-invasive Parenteral Screening Instruments Market Restraints
  • Table 22. Global Non-invasive Parenteral Screening Instruments Sales by Manufacturers (2017-2022) & (Units)
  • Table 23. Global Non-invasive Parenteral Screening Instruments Sales Share by Manufacturers (2017-2022)
  • Table 24. Global Non-invasive Parenteral Screening Instruments Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 25. Ranking of Global Top Non-invasive Parenteral Screening Instruments Manufacturers by Revenue (US$ Million) in 2021
  • Table 26. Non-invasive Parenteral Screening Instruments Revenue Share by Manufacturers (2017-2022)
  • Table 27. Global Non-invasive Parenteral Screening Instruments Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 28. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-invasive Parenteral Screening Instruments as of 2021)
  • Table 29. Key Manufacturers Non-invasive Parenteral Screening Instruments Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
  • Table 30. Key Manufacturers Non-invasive Parenteral Screening Instruments Plants/Factories Distribution
  • Table 31. Key Manufacturers Non-invasive Parenteral Screening Instruments Area Served
  • Table 32. Date of Key Manufacturers Enter into Non-invasive Parenteral Screening Instruments Market
  • Table 33. Key Manufacturers Non-invasive Parenteral Screening Instruments Product Type
  • Table 34. Mergers & Acquisitions, Expansion Plans
  • Table 35. Global Non-invasive Parenteral Screening Instruments Sales (Units) by Type (2017-2022)
  • Table 36. Global Non-invasive Parenteral Screening Instruments Sales Share by Type (2017-2022)
  • Table 37. Global Non-invasive Parenteral Screening Instruments Revenue (US$ Million) Market Share by Type (2017-2022)
  • Table 38. Global Non-invasive Parenteral Screening Instruments Price (Units) by Type (2017-2022)
  • Table 39. Global Non-invasive Parenteral Screening Instruments Sales (Units) by Type (2023-2028)
  • Table 40. Global Non-invasive Parenteral Screening Instruments Sales Share by Type (2023-2028)
  • Table 41. Global Non-invasive Parenteral Screening Instruments Revenue (US$ Million) Market Share by Type (2023-2028)
  • Table 42. Global Non-invasive Parenteral Screening Instruments Revenue Share by Type (2023-2028)
  • Table 43. Global Non-invasive Parenteral Screening Instruments Price (Units) by Type (2023-2028)
  • Table 44. Global Non-invasive Parenteral Screening Instruments Sales (Units) by Application (2017-2022)
  • Table 45. Global Non-invasive Parenteral Screening Instruments Sales Share by Application (2017-2022)
  • Table 46. Global Non-invasive Parenteral Screening Instruments Revenue (US$ Million) Market Share by Application (2017-2022)
  • Table 47. Global Non-invasive Parenteral Screening Instruments Price (Units) by Application (2017-2022)
  • Table 48. Global Non-invasive Parenteral Screening Instruments Sales (Units) by Application (2023-2028)
  • Table 49. Global Non-invasive Parenteral Screening Instruments Sales Share by Application (2023-2028)
  • Table 50. Global Non-invasive Parenteral Screening Instruments Revenue (US$ Million) Market Share by Application (2023-2028)
  • Table 51. Global Non-invasive Parenteral Screening Instruments Revenue Share by Application (2023-2028)
  • Table 52. Global Non-invasive Parenteral Screening Instruments Price (Units) by Application (2023-2028)
  • Table 53. North America Non-invasive Parenteral Screening Instruments Sales by Company (2017-2022) & (Units)
  • Table 54. North America Non-invasive Parenteral Screening Instruments Sales Market Share by Company (2017-2022)
  • Table 55. North America Non-invasive Parenteral Screening Instruments Revenue by Company (2017-2022) & (US$ Million)
  • Table 56. North America Non-invasive Parenteral Screening Instruments Revenue Market Share by Company (2017-2022)
  • Table 57. North America Non-invasive Parenteral Screening Instruments Sales by Type (2017-2022) & (Units)
  • Table 58. North America Non-invasive Parenteral Screening Instruments Sales by Type (2023-2028) & (Units)
  • Table 59. North America Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2022) & (US$ Million)
  • Table 60. North America Non-invasive Parenteral Screening Instruments Revenue by Type (2023-2028) & (US$ Million)
  • Table 61. North America Non-invasive Parenteral Screening Instruments Sales by Application (2017-2022) & (Units)
  • Table 62. North America Non-invasive Parenteral Screening Instruments Sales by Application (2023-2028) & (Units)
  • Table 63. North America Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2022) & (US$ Million)
  • Table 64. North America Non-invasive Parenteral Screening Instruments Revenue by Application (2023-2028) & (US$ Million)
  • Table 65. North America Non-invasive Parenteral Screening Instruments Sales by Country (2017-2022) & (Units)
  • Table 66. North America Non-invasive Parenteral Screening Instruments Sales by Country (2023-2028) & (Units)
  • Table 67. North America Non-invasive Parenteral Screening Instruments Revenue by Country (2017-2022) & (US$ Million)
  • Table 68. North America Non-invasive Parenteral Screening Instruments Revenue by Country (2023-2028) & (US$ Million)
  • Table 69. Europe Non-invasive Parenteral Screening Instruments Sales by Company (2017-2022) & (Units)
  • Table 70. Europe Non-invasive Parenteral Screening Instruments Sales Market Share by Company (2017-2022)
  • Table 71. Europe Non-invasive Parenteral Screening Instruments Revenue by Company (2017-2022) & (US$ Million)
  • Table 72. Europe Non-invasive Parenteral Screening Instruments Revenue Market Share by Company (2017-2022)
  • Table 73. Europe Non-invasive Parenteral Screening Instruments Sales by Type (2017-2022) & (Units)
  • Table 74. Europe Non-invasive Parenteral Screening Instruments Sales by Type (2023-2028) & (Units)
  • Table 75. Europe Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2022) & (US$ Million)
  • Table 76. Europe Non-invasive Parenteral Screening Instruments Revenue by Type (2023-2028) & (US$ Million)
  • Table 77. Europe Non-invasive Parenteral Screening Instruments Sales by Application (2017-2022) & (Units)
  • Table 78. Europe Non-invasive Parenteral Screening Instruments Sales by Application (2023-2028) & (Units)
  • Table 79. Europe Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2022) & (US$ Million)
  • Table 80. Europe Non-invasive Parenteral Screening Instruments Revenue by Application (2023-2028) & (US$ Million)
  • Table 81. Europe Non-invasive Parenteral Screening Instruments Sales by Country (2017-2022) & (Units)
  • Table 82. Europe Non-invasive Parenteral Screening Instruments Sales by Country (2023-2028) & (Units)
  • Table 83. Europe Non-invasive Parenteral Screening Instruments Revenue by Country (2017-2022) & (US$ Million)
  • Table 84. Europe Non-invasive Parenteral Screening Instruments Revenue by Country (2023-2028) & (US$ Million)
  • Table 85. Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Company (2017-2022) & (Units)
  • Table 86. Asia Pacific Non-invasive Parenteral Screening Instruments Sales Market Share by Company (2017-2022)
  • Table 87. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Company (2017-2022) & (US$ Million)
  • Table 88. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue Market Share by Company (2017-2022)
  • Table 89. Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Type (2017-2022) & (Units)
  • Table 90. Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Type (2023-2028) & (Units)
  • Table 91. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2022) & (US$ Million)
  • Table 92. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Type (2023-2028) & (US$ Million)
  • Table 93. Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Application (2017-2022) & (Units)
  • Table 94. Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Application (2023-2028) & (Units)
  • Table 95. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2022) & (US$ Million)
  • Table 96. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Application (2023-2028) & (US$ Million)
  • Table 97. Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Region (2017-2022) & (Units)
  • Table 98. Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Region (2023-2028) & (Units)
  • Table 99. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Region (2017-2022) & (US$ Million)
  • Table 100. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Region (2023-2028) & (US$ Million)
  • Table 101. Latin America Non-invasive Parenteral Screening Instruments Sales by Company (2017-2022) & (Units)
  • Table 102. Latin America Non-invasive Parenteral Screening Instruments Sales Market Share by Company (2017-2022)
  • Table 103. Latin America Non-invasive Parenteral Screening Instruments Revenue by Company (2017-2022) & (US$ Million)
  • Table 104. Latin America Non-invasive Parenteral Screening Instruments Revenue Market Share by Company (2017-2022)
  • Table 105. Latin America Non-invasive Parenteral Screening Instruments Sales by Type (2017-2022) & (Units)
  • Table 106. Latin America Non-invasive Parenteral Screening Instruments Sales by Type (2023-2028) & (Units)
  • Table 107. Latin America Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2022) & (US$ Million)
  • Table 108. Latin America Non-invasive Parenteral Screening Instruments Revenue by Type (2023-2028) & (US$ Million)
  • Table 109. Latin America Non-invasive Parenteral Screening Instruments Sales by Application (2017-2022) & (Units)
  • Table 110. Latin America Non-invasive Parenteral Screening Instruments Sales by Application (2023-2028) & (Units)
  • Table 111. Latin America Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2022) & (US$ Million)
  • Table 112. Latin America Non-invasive Parenteral Screening Instruments Revenue by Application (2023-2028) & (US$ Million)
  • Table 113. Latin America Non-invasive Parenteral Screening Instruments Sales by Country (2017-2022) & (Units)
  • Table 114. Latin America Non-invasive Parenteral Screening Instruments Sales by Country (2023-2028) & (Units)
  • Table 115. Latin America Non-invasive Parenteral Screening Instruments Revenue by Country (2017-2022) & (US$ Million)
  • Table 116. Latin America Non-invasive Parenteral Screening Instruments Revenue by Country (2023-2028) & (US$ Million)
  • Table 117. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Company (2017-2022) & (Units)
  • Table 118. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales Market Share by Company (2017-2022)
  • Table 119. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Company (2017-2022) & (US$ Million)
  • Table 120. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue Market Share by Company (2017-2022)
  • Table 121. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Type (2017-2022) & (Units)
  • Table 122. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Type (2023-2028) & (Units)
  • Table 123. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2022) & (US$ Million)
  • Table 124. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Type (2023-2028) & (US$ Million)
  • Table 125. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Application (2017-2022) & (Units)
  • Table 126. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Application (2023-2028) & (Units)
  • Table 127. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2022) & (US$ Million)
  • Table 128. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Application (2023-2028) & (US$ Million)
  • Table 129. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Country (2017-2022) & (Units)
  • Table 130. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Country (2023-2028) & (Units)
  • Table 131. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Country (2017-2022) & (US$ Million)
  • Table 132. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Country (2023-2028) & (US$ Million)
  • Table 133. GE Healthcare Corporation Information
  • Table 134. GE Healthcare Description and Overview
  • Table 135. GE Healthcare Non-invasive Parenteral Screening Instruments Sales (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
  • Table 136. GE Healthcare Non-invasive Parenteral Screening Instruments Product and Services
  • Table 137. GE Healthcare Non-invasive Parenteral Screening Instruments SWOT Analysis
  • Table 138. GE Healthcare Recent Developments
  • Table 139. Philips Corporation Information
  • Table 140. Philips Description and Overview
  • Table 141. Philips Non-invasive Parenteral Screening Instruments Sales (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
  • Table 142. Philips Non-invasive Parenteral Screening Instruments Product and Services
  • Table 143. Philips Non-invasive Parenteral Screening Instruments SWOT Analysis
  • Table 144. Philips Recent Developments
  • Table 145. Illumina Corporation Information
  • Table 146. Illumina Description and Overview
  • Table 147. Illumina Non-invasive Parenteral Screening Instruments Sales (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
  • Table 148. Illumina Non-invasive Parenteral Screening Instruments Product and Services
  • Table 149. Illumina Non-invasive Parenteral Screening Instruments SWOT Analysis
  • Table 150. Illumina Recent Developments
  • Table 151. Thermo Fisher Scientific Corporation Information
  • Table 152. Thermo Fisher Scientific Description and Overview
  • Table 153. Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Sales (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
  • Table 154. Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Product and Services
  • Table 155. Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments SWOT Analysis
  • Table 156. Thermo Fisher Scientific Recent Developments
  • Table 157. Roche Corporation Information
  • Table 158. Roche Description and Overview
  • Table 159. Roche Non-invasive Parenteral Screening Instruments Sales (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
  • Table 160. Roche Non-invasive Parenteral Screening Instruments Product and Services
  • Table 161. Roche Non-invasive Parenteral Screening Instruments SWOT Analysis
  • Table 162. Roche Recent Developments
  • Table 163. PacBio Corporation Information
  • Table 164. PacBio Description and Overview
  • Table 165. PacBio Non-invasive Parenteral Screening Instruments Sales (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
  • Table 166. PacBio Non-invasive Parenteral Screening Instruments Product and Services
  • Table 167. PacBio Non-invasive Parenteral Screening Instruments SWOT Analysis
  • Table 168. PacBio Recent Developments
  • Table 169. Perkinelmer Corporation Information
  • Table 170. Perkinelmer Description and Overview
  • Table 171. Perkinelmer Non-invasive Parenteral Screening Instruments Sales (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
  • Table 172. Perkinelmer Non-invasive Parenteral Screening Instruments Product and Services
  • Table 173. Perkinelmer Non-invasive Parenteral Screening Instruments SWOT Analysis
  • Table 174. Perkinelmer Recent Developments
  • Table 175. Qiagen Corporation Information
  • Table 176. Qiagen Description and Overview
  • Table 177. Qiagen Non-invasive Parenteral Screening Instruments Sales (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
  • Table 178. Qiagen Non-invasive Parenteral Screening Instruments Product and Services
  • Table 179. Qiagen Non-invasive Parenteral Screening Instruments SWOT Analysis
  • Table 180. Qiagen Recent Developments
  • Table 181. Agilent Technologies Corporation Information
  • Table 182. Agilent Technologies Description and Overview
  • Table 183. Agilent Technologies Non-invasive Parenteral Screening Instruments Sales (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
  • Table 184. Agilent Technologies Non-invasive Parenteral Screening Instruments Product and Services
  • Table 185. Agilent Technologies Non-invasive Parenteral Screening Instruments SWOT Analysis
  • Table 186. Agilent Technologies Recent Developments
  • Table 187. BGI Group Corporation Information
  • Table 188. BGI Group Description and Overview
  • Table 189. BGI Group Non-invasive Parenteral Screening Instruments Sales (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
  • Table 190. BGI Group Non-invasive Parenteral Screening Instruments Product and Services
  • Table 191. BGI Group Non-invasive Parenteral Screening Instruments SWOT Analysis
  • Table 192. BGI Group Recent Developments
  • Table 193. Key Raw Materials Lists
  • Table 194. Raw Materials Key Suppliers Lists
  • Table 195. Non-invasive Parenteral Screening Instruments Distributors List
  • Table 196. Non-invasive Parenteral Screening Instruments Customers List
  • Table 197. Research Programs/Design for This Report
  • Table 198. Key Data Information from Secondary Sources
  • Table 199. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Non-invasive Parenteral Screening Instruments Product Picture
  • Figure 2. Global Non-invasive Parenteral Screening Instruments Sales Market Share by Type in 2021 & 2028
  • Figure 3. Ultrasound Devices Product Picture
  • Figure 4. Next-Generation Sequencing Systems Product Picture
  • Figure 5. Polymerase Chain Reaction Instruments Product Picture
  • Figure 6. Microarrays Product Picture
  • Figure 7. Others Product Picture
  • Figure 8. Global Non-invasive Parenteral Screening Instruments Sales Market Share by Application in 2021 & 2028
  • Figure 9. Diagnostic Laboratories Use Case
  • Figure 10. Hospitals Use Case
  • Figure 11. Non-invasive Parenteral Screening Instruments Report Years Considered
  • Figure 12. Global Non-invasive Parenteral Screening Instruments Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 13. Global Non-invasive Parenteral Screening Instruments Market Size 2017-2028 (US$ Million)
  • Figure 14. Global Non-invasive Parenteral Screening Instruments Sales (2017-2022) & (Units)
  • Figure 15. Global Non-invasive Parenteral Screening Instruments Market Size Market Share by Region: 2021 VS 2028
  • Figure 16. Global Non-invasive Parenteral Screening Instruments Sales Market Share by Region (2017-2022)
  • Figure 17. Global Non-invasive Parenteral Screening Instruments Sales Market Share by Region in 2021
  • Figure 18. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Region in 2017 VS 2021
  • Figure 19. Global Non-invasive Parenteral Screening Instruments Sales Share by Manufacturers in 2021
  • Figure 20. The 5 and 10 Largest Manufacturers in the World: Market Share by Non-invasive Parenteral Screening Instruments Sales in 2021
  • Figure 21. Non-invasive Parenteral Screening Instruments Revenue Share by Manufacturers in 2021
  • Figure 22. Non-invasive Parenteral Screening Instruments Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
  • Figure 23. Global Non-invasive Parenteral Screening Instruments Revenue Share by Type (2017-2022)
  • Figure 24. Global Non-invasive Parenteral Screening Instruments Revenue Growth Rate by Type in 2017 & 2021
  • Figure 25. Global Non-invasive Parenteral Screening Instruments Revenue Share by Application (2017-2022)
  • Figure 26. Global Non-invasive Parenteral Screening Instruments Revenue Growth Rate by Application in 2017 & 2021
  • Figure 27. North America Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2017-2028)
  • Figure 28. North America Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2017-2028)
  • Figure 29. North America Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2017-2028)
  • Figure 30. North America Non-invasive Parenteral Screening Instruments Revenue Market Share by Application (2017-2028)
  • Figure 31. North America Non-invasive Parenteral Screening Instruments Sales Share by Country (2017-2028)
  • Figure 32. North America Non-invasive Parenteral Screening Instruments Revenue Share by Country (2017-2028)
  • Figure 33. U.S. Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
  • Figure 34. Canada Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
  • Figure 35. Europe Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2017-2028)
  • Figure 36. Europe Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2017-2028)
  • Figure 37. Europe Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2017-2028)
  • Figure 38. Europe Non-invasive Parenteral Screening Instruments Revenue Market Share by Application (2017-2028)
  • Figure 39. Europe Non-invasive Parenteral Screening Instruments Sales Share by Country (2017-2028)
  • Figure 40. Europe Non-invasive Parenteral Screening Instruments Revenue Share by Country (2017-2028)
  • Figure 41. Germany Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
  • Figure 42. France Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
  • Figure 43. U.K. Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
  • Figure 44. Italy Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
  • Figure 45. Russia Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
  • Figure 46. Asia Pacific Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2017-2028)
  • Figure 47. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2017-2028)
  • Figure 48. Asia Pacific Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2017-2028)
  • Figure 49. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue Market Share by Application (2017-2028)
  • Figure 50. Asia Pacific Non-invasive Parenteral Screening Instruments Sales Share by Region (2017-2028)
  • Figure 51. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue Share by Region (2017-2028)
  • Figure 52. China Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
  • Figure 53. Japan Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
  • Figure 54. South Korea Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
  • Figure 55. India Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
  • Figure 56. Australia Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
  • Figure 57. Taiwan Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
  • Figure 58. Indonesia Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
  • Figure 59. Thailand Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
  • Figure 60. Malaysia Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
  • Figure 61. Philippines Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
  • Figure 62. Vietnam Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
  • Figure 63. Latin America Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2017-2028)
  • Figure 64. Latin America Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2017-2028)
  • Figure 65. Latin America Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2017-2028)
  • Figure 66. Latin America Non-invasive Parenteral Screening Instruments Revenue Market Share by Application (2017-2028)
  • Figure 67. Latin America Non-invasive Parenteral Screening Instruments Sales Share by Country (2017-2028)
  • Figure 68. Latin America Non-invasive Parenteral Screening Instruments Revenue Share by Country (2017-2028)
  • Figure 69. Mexico Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
  • Figure 70. Brazil Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
  • Figure 71. Argentina Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
  • Figure 72. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2017-2028)
  • Figure 73. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2017-2028)
  • Figure 74. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2017-2028)
  • Figure 75. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue Market Share by Application (2017-2028)
  • Figure 76. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales Share by Country (2017-2028)
  • Figure 77. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue Share by Country (2017-2028)
  • Figure 78. Turkey Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
  • Figure 79. Saudi Arabia Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
  • Figure 80. U.A.E Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million)
  • Figure 81. Non-invasive Parenteral Screening Instruments Value Chain
  • Figure 82. Non-invasive Parenteral Screening Instruments Production Process
  • Figure 83. Channels of Distribution
  • Figure 84. Distributors Profiles
  • Figure 85. Bottom-up and Top-down Approaches for This Report
  • Figure 86. Data Triangulation
  • Figure 87. Key Executives Interviewed
目次

This research report focuses on the Non-invasive Parenteral Screening Instruments Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Research Scope
  • 1.2 Market Segment by Type
    • 1.2.1 Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
    • 1.2.2 Ultrasound Devices
    • 1.2.3 Next-Generation Sequencing Systems
    • 1.2.4 Polymerase Chain Reaction Instruments
    • 1.2.5 Microarrays
    • 1.2.6 Others
  • 1.3 Market Segment by Application
    • 1.3.1 Global Non-invasive Parenteral Screening Instruments Market Share by Application (2017 VS 2021 VS 2028)
    • 1.3.2 Diagnostic Laboratories
    • 1.3.3 Hospitals
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Market Perspective

  • 2.1 Global Non-invasive Parenteral Screening Instruments Market Size (2017-2028)
    • 2.1.1 Global Non-invasive Parenteral Screening Instruments Revenue (2017-2028)
    • 2.1.2 Global Non-invasive Parenteral Screening Instruments Sales (2017-2028)
  • 2.2 Global Non-invasive Parenteral Screening Instruments Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
    • 2.2.1 Global Non-invasive Parenteral Screening Instruments Sales by Regions (2017-2022)
    • 2.2.2 Global Non-invasive Parenteral Screening Instruments Revenue by Regions (2017-2022)
  • 2.3 Global Non-invasive Parenteral Screening Instruments Market Size Forecast by Region
    • 2.3.1 Global Non-invasive Parenteral Screening Instruments Sales Forecast by Region (2023-2028)
    • 2.3.2 Global Non-invasive Parenteral Screening Instruments Revenue Forecast by Region (2023-2028)
  • 2.4 Global Top Non-invasive Parenteral Screening Instruments Regions (Countries) Ranking by Market Size
  • 2.5 Non-invasive Parenteral Screening Instruments Market Dynamics
    • 2.5.1 Non-invasive Parenteral Screening Instruments Market Trends
    • 2.5.2 Non-invasive Parenteral Screening Instruments Market Drivers
    • 2.5.3 Non-invasive Parenteral Screening Instruments Market Challenges
    • 2.5.4 Non-invasive Parenteral Screening Instruments Market Restraints

3 Competitive Landscape by Manufacturers

  • 3.1 Global Top Non-invasive Parenteral Screening Instruments Manufacturers by Sales (2017-2022)
    • 3.1.1 Global Non-invasive Parenteral Screening Instruments Sales by Manufacturers (2017-2022)
    • 3.1.2 Global Non-invasive Parenteral Screening Instruments Sales Market Share by Manufacturers (2017-2022)
    • 3.1.3 Global 5 and 10 Largest Manufacturers by Non-invasive Parenteral Screening Instruments Sales in 2021
  • 3.2 Global Top Manufacturers Non-invasive Parenteral Screening Instruments by Revenue
    • 3.2.1 Global Non-invasive Parenteral Screening Instruments Revenue by Manufacturers (2017-2022)
    • 3.2.2 Top Non-invasive Parenteral Screening Instruments Manufacturers Covered: Ranking by Revenue
    • 3.2.3 Global Non-invasive Parenteral Screening Instruments Revenue Share by Manufacturers (2017-2022)
    • 3.2.4 Global Non-invasive Parenteral Screening Instruments Market Concentration Ratio (CR5 and HHI)
  • 3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-invasive Parenteral Screening Instruments as of 2021)
  • 3.4 Global Non-invasive Parenteral Screening Instruments Average Selling Price (ASP) by Manufacturers
  • 3.5 Key Manufacturers Non-invasive Parenteral Screening Instruments Plants/Factories Distribution and Area Served
  • 3.6 Date of Key Manufacturers Enter into Non-invasive Parenteral Screening Instruments Market
  • 3.7 Key Manufacturers Non-invasive Parenteral Screening Instruments Product Offered
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Global Non-invasive Parenteral Screening Instruments Market Size by Type

  • 4.1 Global Non-invasive Parenteral Screening Instruments Historic Market Review by Type (2017-2022)
    • 4.1.1 Global Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2017-2022)
    • 4.1.2 Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2017-2022)
    • 4.1.3 Non-invasive Parenteral Screening Instruments Price by Type (2017-2022)
  • 4.2 Global Non-invasive Parenteral Screening Instruments Market Estimates and Forecasts by Type (2023-2028)
    • 4.2.1 Global Non-invasive Parenteral Screening Instruments Sales Forecast by Type (2023-2028)
    • 4.2.2 Global Non-invasive Parenteral Screening Instruments Revenue Forecast by Type (2023-2028)
    • 4.2.3 Non-invasive Parenteral Screening Instruments Price Forecast by Type (2023-2028)

5 Global Non-invasive Parenteral Screening Instruments Market Size by Application

  • 5.1 Global Non-invasive Parenteral Screening Instruments Historic Market Review by Application (2017-2022)
    • 5.1.1 Global Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2017-2022)
    • 5.1.2 Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Application (2017-2022)
    • 5.1.3 Non-invasive Parenteral Screening Instruments Price by Application (2017-2022)
  • 5.2 Global Non-invasive Parenteral Screening Instruments Market Estimates and Forecasts by Application (2023-2028)
    • 5.2.1 Global Non-invasive Parenteral Screening Instruments Sales Forecast by Application (2023-2028)
    • 5.2.2 Global Non-invasive Parenteral Screening Instruments Revenue Forecast by Application (2023-2028)
    • 5.2.3 Non-invasive Parenteral Screening Instruments Price Forecast by Application (2023-2028)

6 North America

  • 6.1 North America Non-invasive Parenteral Screening Instruments Sales Breakdown by Company
    • 6.1.1 North America Non-invasive Parenteral Screening Instruments Sales by Company (2017-2022)
    • 6.1.2 North America Non-invasive Parenteral Screening Instruments Revenue by Company (2017-2022)
  • 6.2 North America Non-invasive Parenteral Screening Instruments Market Size by Type
    • 6.2.1 North America Non-invasive Parenteral Screening Instruments Sales by Type (2017-2028)
    • 6.2.2 North America Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2028)
  • 6.3 North America Non-invasive Parenteral Screening Instruments Market Size by Application
    • 6.3.1 North America Non-invasive Parenteral Screening Instruments Sales by Application (2017-2028)
    • 6.3.2 North America Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2028)
  • 6.4 North America Non-invasive Parenteral Screening Instruments Market Size by Country
    • 6.4.1 North America Non-invasive Parenteral Screening Instruments Sales by Country (2017-2028)
    • 6.4.2 North America Non-invasive Parenteral Screening Instruments Revenue by Country (2017-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Non-invasive Parenteral Screening Instruments Sales Breakdown by Company
    • 7.1.1 Europe Non-invasive Parenteral Screening Instruments Sales by Company (2017-2022)
    • 7.1.2 Europe Non-invasive Parenteral Screening Instruments Revenue by Company (2017-2022)
  • 7.2 Europe Non-invasive Parenteral Screening Instruments Market Size by Type
    • 7.2.1 Europe Non-invasive Parenteral Screening Instruments Sales by Type (2017-2028)
    • 7.2.2 Europe Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2028)
  • 7.3 Europe Non-invasive Parenteral Screening Instruments Market Size by Application
    • 7.3.1 Europe Non-invasive Parenteral Screening Instruments Sales by Application (2017-2028)
    • 7.3.2 Europe Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2028)
  • 7.4 Europe Non-invasive Parenteral Screening Instruments Market Size by Country
    • 7.4.1 Europe Non-invasive Parenteral Screening Instruments Sales by Country (2017-2028)
    • 7.4.2 Europe Non-invasive Parenteral Screening Instruments Revenue by Country (2017-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Non-invasive Parenteral Screening Instruments Sales Breakdown by Company
    • 8.1.1 Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Company (2017-2022)
    • 8.1.2 Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Company (2017-2022)
  • 8.2 Asia Pacific Non-invasive Parenteral Screening Instruments Market Size by Type
    • 8.2.1 Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Type (2017-2028)
    • 8.2.2 Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2028)
  • 8.3 Asia Pacific Non-invasive Parenteral Screening Instruments Market Size by Application
    • 8.3.1 Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Application (2017-2028)
    • 8.3.2 Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2028)
  • 8.4 Asia Pacific Non-invasive Parenteral Screening Instruments Market Size by Region
    • 8.4.1 Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Region
    • 8.4.2 Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Region
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 India
    • 8.4.7 Australia
    • 8.4.8 Taiwan
    • 8.4.9 Indonesia
    • 8.4.10 Thailand
    • 8.4.11 Malaysia
    • 8.4.12 Philippines
    • 8.4.13 Vietnam

9 Latin America

  • 9.1 Latin America Non-invasive Parenteral Screening Instruments Sales Breakdown by Company
    • 9.1.1 Latin America Non-invasive Parenteral Screening Instruments Sales by Company (2017-2022)
    • 9.1.2 Latin America Non-invasive Parenteral Screening Instruments Revenue by Company (2017-2022)
  • 9.2 Latin America Non-invasive Parenteral Screening Instruments Market Size by Type
    • 9.2.1 Latin America Non-invasive Parenteral Screening Instruments Sales by Type (2017-2028)
    • 9.2.2 Latin America Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2028)
  • 9.3 Latin America Non-invasive Parenteral Screening Instruments Market Size by Application
    • 9.3.1 Latin America Non-invasive Parenteral Screening Instruments Sales by Application (2017-2028)
    • 9.3.2 Latin America Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2028)
  • 9.4 Latin America Non-invasive Parenteral Screening Instruments Market Size by Country
    • 9.4.1 Latin America Non-invasive Parenteral Screening Instruments Sales by Country (2017-2028)
    • 9.4.2 Latin America Non-invasive Parenteral Screening Instruments Revenue by Country (2017-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil
    • 9.4.5 Argentina

10 Middle East and Africa

  • 10.1 Middle East and Africa Non-invasive Parenteral Screening Instruments Sales Breakdown by Company
    • 10.1.1 Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Company (2017-2022)
    • 10.1.2 Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Company (2017-2022)
  • 10.2 Middle East and Africa Non-invasive Parenteral Screening Instruments Market Size by Type
    • 10.2.1 Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Type (2017-2028)
    • 10.2.2 Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2028)
  • 10.3 Middle East and Africa Non-invasive Parenteral Screening Instruments Market Size by Application
    • 10.3.1 Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Application (2017-2028)
    • 10.3.2 Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2028)
  • 10.4 Middle East and Africa Non-invasive Parenteral Screening Instruments Market Size by Country
    • 10.4.1 Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Country (2017-2028)
    • 10.4.2 Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Country (2017-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 U.A.E

11 Company Profiles

  • 11.1 GE Healthcare
    • 11.1.1 GE Healthcare Corporation Information
    • 11.1.2 GE Healthcare Overview
    • 11.1.3 GE Healthcare Non-invasive Parenteral Screening Instruments Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
    • 11.1.4 GE Healthcare Non-invasive Parenteral Screening Instruments Products and Services
    • 11.1.5 GE Healthcare Non-invasive Parenteral Screening Instruments SWOT Analysis
    • 11.1.6 GE Healthcare Recent Developments
  • 11.2 Philips
    • 11.2.1 Philips Corporation Information
    • 11.2.2 Philips Overview
    • 11.2.3 Philips Non-invasive Parenteral Screening Instruments Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
    • 11.2.4 Philips Non-invasive Parenteral Screening Instruments Products and Services
    • 11.2.5 Philips Non-invasive Parenteral Screening Instruments SWOT Analysis
    • 11.2.6 Philips Recent Developments
  • 11.3 Illumina
    • 11.3.1 Illumina Corporation Information
    • 11.3.2 Illumina Overview
    • 11.3.3 Illumina Non-invasive Parenteral Screening Instruments Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
    • 11.3.4 Illumina Non-invasive Parenteral Screening Instruments Products and Services
    • 11.3.5 Illumina Non-invasive Parenteral Screening Instruments SWOT Analysis
    • 11.3.6 Illumina Recent Developments
  • 11.4 Thermo Fisher Scientific
    • 11.4.1 Thermo Fisher Scientific Corporation Information
    • 11.4.2 Thermo Fisher Scientific Overview
    • 11.4.3 Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
    • 11.4.4 Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Products and Services
    • 11.4.5 Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments SWOT Analysis
    • 11.4.6 Thermo Fisher Scientific Recent Developments
  • 11.5 Roche
    • 11.5.1 Roche Corporation Information
    • 11.5.2 Roche Overview
    • 11.5.3 Roche Non-invasive Parenteral Screening Instruments Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
    • 11.5.4 Roche Non-invasive Parenteral Screening Instruments Products and Services
    • 11.5.5 Roche Non-invasive Parenteral Screening Instruments SWOT Analysis
    • 11.5.6 Roche Recent Developments
  • 11.6 PacBio
    • 11.6.1 PacBio Corporation Information
    • 11.6.2 PacBio Overview
    • 11.6.3 PacBio Non-invasive Parenteral Screening Instruments Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
    • 11.6.4 PacBio Non-invasive Parenteral Screening Instruments Products and Services
    • 11.6.5 PacBio Non-invasive Parenteral Screening Instruments SWOT Analysis
    • 11.6.6 PacBio Recent Developments
  • 11.7 Perkinelmer
    • 11.7.1 Perkinelmer Corporation Information
    • 11.7.2 Perkinelmer Overview
    • 11.7.3 Perkinelmer Non-invasive Parenteral Screening Instruments Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
    • 11.7.4 Perkinelmer Non-invasive Parenteral Screening Instruments Products and Services
    • 11.7.5 Perkinelmer Non-invasive Parenteral Screening Instruments SWOT Analysis
    • 11.7.6 Perkinelmer Recent Developments
  • 11.8 Qiagen
    • 11.8.1 Qiagen Corporation Information
    • 11.8.2 Qiagen Overview
    • 11.8.3 Qiagen Non-invasive Parenteral Screening Instruments Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
    • 11.8.4 Qiagen Non-invasive Parenteral Screening Instruments Products and Services
    • 11.8.5 Qiagen Non-invasive Parenteral Screening Instruments SWOT Analysis
    • 11.8.6 Qiagen Recent Developments
  • 11.9 Agilent Technologies
    • 11.9.1 Agilent Technologies Corporation Information
    • 11.9.2 Agilent Technologies Overview
    • 11.9.3 Agilent Technologies Non-invasive Parenteral Screening Instruments Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
    • 11.9.4 Agilent Technologies Non-invasive Parenteral Screening Instruments Products and Services
    • 11.9.5 Agilent Technologies Non-invasive Parenteral Screening Instruments SWOT Analysis
    • 11.9.6 Agilent Technologies Recent Developments
  • 11.10 BGI Group
    • 11.10.1 BGI Group Corporation Information
    • 11.10.2 BGI Group Overview
    • 11.10.3 BGI Group Non-invasive Parenteral Screening Instruments Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
    • 11.10.4 BGI Group Non-invasive Parenteral Screening Instruments Products and Services
    • 11.10.5 BGI Group Non-invasive Parenteral Screening Instruments SWOT Analysis
    • 11.10.6 BGI Group Recent Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Non-invasive Parenteral Screening Instruments Value Chain Analysis
  • 12.2 Non-invasive Parenteral Screening Instruments Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Non-invasive Parenteral Screening Instruments Production Mode & Process
  • 12.4 Non-invasive Parenteral Screening Instruments Sales and Marketing
    • 12.4.1 Non-invasive Parenteral Screening Instruments Sales Channels
    • 12.4.2 Non-invasive Parenteral Screening Instruments Distributors
  • 12.5 Non-invasive Parenteral Screening Instruments Customers

13 Research Findings and Conclusion

14 Appendix

  • 14.1 Research Methodology
    • 14.1.1 Methodology/Research Approach
    • 14.1.2 Data Source
  • 14.2 Author Details
  • 14.3 Disclaimer